Physician profile
Ramon C Raneses
NPI 1205812856
$2,843.81
in general payments reported to CMS, 2019-2025
29 companies · $98.85 in 2025
The $98.85 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $752 · 2020: $398 · 2021: $564 · 2022: $588 · 2023: $328 · 2024: $115 · 2025: $98.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $812.28 | 2019-2023 | Pressurewire |
| Novartis Pharmaceuticals Corporation | $495.53 | 2019-2022 | |
| Shockwave Medical, INC | $276.22 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $145.77 | 2022-2025 | Impella |
| Amgen INC. | $145.39 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $111.39 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.25 | 2020-2023 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $72.08 | 2022 | |
| Boston Scientific Corporation | $70.64 | 2019-2024 | Resonate El Icd Vr |
| Inari Medical, INC. | $69.41 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $69.16 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $63.73 | 2021-2022 | |
| Heartflow, INC. | $52.77 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.87 | 2020-2022 | |
| Edwards Lifesciences Corporation | $43.18 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $41.23 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.10 | 2020 | |
| Cardinal Health 200 LLC | $27.34 | 2020-2021 | |
| Ge Healthcare | $22.91 | 2020 | |
| Ethicon US, LLC | $19.98 | 2021 | |
| Lundbeck LLC | $19.83 | 2021 | |
| Medtronic Vascular, INC. | $18.54 | 2019 | |
| Teleflex LLC | $17.39 | 2023 | Guideliner |
| Astrazeneca Pharmaceuticals LP | $15.08 | 2022 | |
| Bardy Diagnostics, INC. | $14.10 | 2022 | |
| Esperion Therapeutics, INC. | $13.54 | 2020 | |
| Kestra Medical Technology Services, INC. | $13.13 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.46 | 2019 | |
| Penumbra, INC. | $10.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Raneses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.